E Comets
Overview
    Explore the profile of E Comets including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              22
            
            
              Citations
              402
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Toumazi A, Comets E, Alberti C, Friede T, Lentz F, Stallard N, et al.
  
  
    Comput Methods Programs Biomed
    . 2018 Feb;
          157:163-177.
    
    PMID: 29477425
  
  
          Background And Objective: Dose-finding, aiming at finding the maximum tolerated dose, and pharmacokinetics studies are the first in human studies in the development process of a new pharmacological treatment. In...
      
2.
        
    
    Cerou M, Lavielle M, Brendel K, Chenel M, Comets E
  
  
    Pharm Res
    . 2018 Jan;
          35(2):30.
    
    PMID: 29368033
  
  
          Purpose: Normalised prediction distribution errors (npde) are used to graphically and statistically evaluate mixed-effect models for continuous responses. In this study, our aim was to extend npde to time-to-event (TTE)...
      
3.
        
    
    Bizzotto R, Comets E, Smith G, Yvon F, Kristensen N, Swat M
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2017 Jun;
          6(10):651-665.
    
    PMID: 28575551
  
  
          PharmML is an XML-based exchange format created with a focus on nonlinear mixed-effect (NLME) models used in pharmacometrics, but providing a very general framework that also allows describing mathematical and...
      
4.
        
    
    Nguyen T, Mouksassi M, Holford N, Al-Huniti N, Freedman I, Hooker A, et al.
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2016 Nov;
          6(2):87-109.
    
    PMID: 27884052
  
  
          This article represents the first in a series of tutorials on model evaluation in nonlinear mixed effect models (NLMEMs), from the International Society of Pharmacometrics (ISoP) Model Evaluation Group. Numerous...
      
5.
        
    
    Tessier A, Bertrand J, Chenel M, Comets E
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2016 Apr;
          5(3):123-31.
    
    PMID: 27069775
  
  
          We show through a simulation study how the joint analysis of data from phase I and phase II studies enhances the power of pharmacogenetic tests in pharmacokinetic (PK) studies. PK...
      
6.
        
    
    Swat M, Moodie S, Wimalaratne S, Kristensen N, Lavielle M, Mari A, et al.
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2015 Jul;
          4(6):316-9.
    
    PMID: 26225259
  
  
          The lack of a common exchange format for mathematical models in pharmacometrics has been a long-standing problem. Such a format has the potential to increase productivity and analysis quality, simplify...
      
7.
        
    
    Gregoire N, Mimoz O, Megarbane B, Comets E, Chatelier D, Lasocki S, et al.
  
  
    Antimicrob Agents Chemother
    . 2014 Oct;
          58(12):7324-30.
    
    PMID: 25267662
  
  
          Colistin is an old antibiotic that has recently gained a considerable renewal of interest as the last-line defense therapy against multidrug-resistant Gram-negative bacteria. It is administered as colistin methanesulfonate (CMS),...
      
8.
        
    
    Mentre F, Chenel M, Comets E, Grevel J, Hooker A, Karlsson M, et al.
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2013 Jul;
          2:e46.
    
    PMID: 23887744
  
  
          No abstract available.
      
9.
        
    
    Vlasakakis G, Comets E, Keunecke A, Gueorguieva I, Magni P, Terranova N, et al.
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2013 Jul;
          2:e40.
    
    PMID: 23887723
  
  
          Pharmaceutical sciences experts and regulators acknowledge that pharmaceutical development as well as drug usage requires more than scientific advancements to cope with current attrition rates/therapeutic failures. Drug disease modeling and...
      
10.
        
    
    Comets E, Diquet B, Legrain S, Huisse M, Godon A, Bruhat C, et al.
  
  
    Clin Pharmacol Ther
    . 2012 Apr;
          91(5):777-86.
    
    PMID: 22472992
  
  
          In the PREPA observational study, we investigated the factors influencing pharmacokinetic and pharmacodynamic variability in the responses to fluindione, an oral anticoagulant drug, in a general population of octogenarian inpatients.Measurements...